Navigation Links
ResMed's New Nasal Pillows System is Our Quietest Yet; Ultra-light AirFit P10 Packs Powerful Performance in Just over 1.5 Ounces
Date:1/13/2014

SAN DIEGO, Jan. 13, 2014 /PRNewswire/ -- ResMed (NYSE: RMD) continues its 25-year history of innovating powerful and comfortable solutions for treating sleep-disordered breathing with today's introduction of the ultra-light, ultra-quiet ResMed AirFit™ P10 nasal pillows system.

(Photo:  http://photos.prnewswire.com/prnh/20140113/LA44444-a)

(Photo:  http://photos.prnewswire.com/prnh/20140113/LA44444-b)

(Logo:  http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

The AirFit P10 weighs just 1.6 ounces, and has only three parts, including a new soft and stable QuickFit™ headgear. ResMed has pioneered a new mesh vent called QuietAir™ so the AirFit P10 is 50 percent quieter than its predecessor, diffusing air with minimal disturbance to patients or their bed partners. ResMed's AirFit P10 maintains a secure seal while delivering a high level of facial freedom.

"The AirFit P10's light weight and ultra-quiet performance also translates directly into better compliance," said Jon Yerbury, vice president of ResMed's Sleep-Disordered Breathing Strategic Business Unit. "Our internal research has shown that the AirFit P10 provides an average of 40 more minutes of sleep per night than ResMed's current market-leading nasal pillows mask."

For the convenience of ResMed's home medical equipment provider customers as well as patients, the AirFit P10 has color-coded cushion sizing, with small, medium and large sizes in the standard AirFit P10 system, and extra-small, small and medium sizes in the AirFit For Her system, which features headgear designed for women.

ResMed's AirFit P10 begins shipping in the U.S. today.

About ResMed: ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com. Contacts:For News MediaFor InvestorsGretchen Griswold

David PendarvisDirector, Global Corporate Communications

Chief Administrative Officer and GlobalO: 858-836-6789

General Counselnews@resmed.com

O: 858-836-5983David.Pendarvis@ResMed.com


'/>"/>
SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Initial Data from Lightlake Therapeutics Joint Clinical Trial with NIDA Shows Nasal Delivery of Naloxone for Opioid Overdose as a Promising Treatment
2. Systematic Review Finds Intranasal Midazolam Comparable To Intravenous Or Rectal Administration Of Diazepam For Treatment Of Acute Seizure Emergencies In Pediatric Patients
3. ResMeds New Nasal Mask Sets the Bar for Comfort and Performance
4. Considering Corticosteroid Nasal Sprays
5. North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 20
6. Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261 (Intranasal Midazolam) For Rescue Treatment Of Seizure Clusters In Epilepsy
7. Aegis Awarded 2nd Patent for Fast Acting Migraine Nasal Spray Treatment
8. Besins Healthcare, Shin Nippon Biomedical Laboratories, Ltd Announce Delivery Technology Licensing Agreement for Intranasal Progesterone
9. Emerging Data on USL261 (Intranasal Midazolam) to Be Presented at the 66th Annual Meeting of the American Epilepsy Society
10. Sleep Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, Respiratory Polygraphs, Pulse Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, Competitive Landsc
11. US Intranasal Drug Delivery Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone ... executive with extensive sequencing and genomics experience, as Vice President of North American Capital ... will be responsible for leading the sales team in the commercialization of the HTG ...
Breaking Medicine News(10 mins):